The higher strength will improve compliance for patients by effectively reducing the number of tablets required per day, Glenmark said in a statement.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ic12p9
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Glenmark to launch higher strength of FabiFlu for mild and moderate symptoms of Covid-19
0 comments:
Post a Comment